| Bioactivity | 3-Methyl-5-β-D-ribofuranosyl-2,4(1H,3H)-pyrimidinedione is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 3-Methyl-5-β-D-ribofuranosyl-2,4(1H,3H)-pyrimidinedione |
| CAS | 81691-06-7 |
| Formula | C10H14N2O6 |
| Molar Mass | 258.23 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
3-Methyl-5-β-D-ribofuranosyl-2,4(1H,3H)-pyrimidinedione
CAS: 81691-06-7 F: C10H14N2O6 W: 258.23
3-Methyl-5-β-D-ribofuranosyl-2,4(1H,3H)-pyrimidinedione is a purine nucleoside analogue. Purine nucleoside analogs have
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.